Gibson Dunn adds life sciences partner to firm

Gibson, Dunn & Crutcher LLP has named Karen Spindler to its San Francisco office. Spindler is a former partner at Goodwin Procter. In her new role at Gibson Dunn, Spindler will advise continue to focus on advising life sciences companies on deals.

PRESS RELEASE

March 17, 2020 – San Francisco. Gibson, Dunn & Crutcher LLP is pleased to announce that Karen Spindler has joined the firm’s San Francisco office. Spindler, formerly a partner at Goodwin Procter, will continue to focus on advising life sciences companies on complex corporate, commercial and intellectual property transactions.

“We welcome Karen to the firm,” said Ken Doran, Chairman and Managing Partner of Gibson Dunn. “Karen has led complex and high-profile transactions in the life sciences space and is well-regarded for her technical skills in IP licensing and collaboration transactions for biotech and pharmaceutical clients. Her practice is highly complementary to our life sciences practice.”

“I’m thrilled to have Karen on board,” said Ryan Murr, Co-Chair of the Life Sciences Practice Group. “She is an extremely capable and versatile life sciences lawyer with extensive experience representing biotechnology and pharmaceutical companies. She is a terrific addition to our corporate practice, and, with her expertise leading high-end pharmaceutical licensing and collaboration transactions, she will be a key addition as we continue to expand in the life sciences space.”

“I’m excited to be joining Gibson Dunn to contribute to the build-out of its life sciences team. Gibson Dunn has a terrific reputation as a leading law firm with institutionalized life sciences clients complementary to my practice. And, just as important, Gibson Dunn is a place where people love to practice law. I’m eager to get started,” said Spindler.

About Karen Spindler
Spindler has considerable experience structuring complex strategic collaboration and partnering transactions, including co-development, co-commercialization and joint venture arrangements, and advising on manufacturing and supply agreements, services arrangements and academic licenses. She represents the full spectrum of companies in the life sciences sector, including companies operating in the areas of pharmaceuticals, biologics, diagnostics, medical devices and bio-agriculture space. In addition, she regularly counsels operating companies on complex IP issues arising in the context of corporate transactions, including mergers, product acquisitions, product spin-outs and other structured M&A transactions, and financial investors and company sellers in royalty monetization agreements.

Before joining the firm, Spindler was a partner at Goodwin Procter for several years in its San Francisco office. Prior, she was a partner at Kirkland & Ellis in its San Francisco and Palo Alto offices.
She received her law degree, magna cum laude, from Santa Clara University School of Law, where she was a member of the Order of the Coif and Senior Production editor of the Computer and High Technology Law Journal. She received her B.S. in biology with honors from Stanford University.

About Gibson Dunn
Gibson, Dunn & Crutcher LLP is a leading international law firm. Consistently ranking among the world’s top law firms in industry surveys and major publications, Gibson Dunn is distinctively positioned in today’s global marketplace with more than 1,300 lawyers and 20 offices, including Beijing, Brussels, Century City, Dallas, Denver, Dubai, Frankfurt, Hong Kong, Houston, London, Los Angeles, Munich, New York, Orange County, Palo Alto, Paris, San Francisco, São Paulo, Singapore, and Washington, D.C. For more information on Gibson Dunn, please visit our website.